GWAY Financial Facts

Net loss per common share - basic and diluted: -0.53
NET LOSS: -43.08M
See Full Income Statement

Accounts payable and accrued expenses: 6.11M
Deferred revenue: 34K
See Full Balance Sheet

Earnings History for Greenway Medical Technologies (GWAY)

  |   Expand Research on GWAY
Next EPS Date 8/28/13 *Est. EPS Growth Rate -87.5% *Last Qtr.
Average EPS % Beat Rate -31.2% Revenue Growth Rate +2.7% *Last Qtr.
Average % Move 1-Wk after EPS -1.2%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/6/13 Q313 $0.01$0.07 -$0.06$33.8M$38.56M N/A / N/A -1.4% Details
2/12/13 Q213 $0.00$0.04 -$0.04$32.7M$35.62M N/A / N/A -21% Details
8/29/12 Q412 $0.10$0.09 +$0.01$36.4M$34.36M N/A / N/A -28.8% Details
11/1/12 Q113 $0.03$0.02 +$0.01$32.8M$32.17M N/A / N/A -31.4% Details
5/10/12 Q312 $0.08$0.04 +$0.04$32.9M$28.54M N/A / N/A N/A -4.5% Details
3/13/12 Q211 $1.70N/A N/A $29.1M$22.3M N/A / N/A N/A +361.6% Details
Like GWAY Earnings? Also take a look at QSII, MDRX, ATHN, SI

GWAY Earnings News